COMMUNIQUÉS West-GlobeNewswire

FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
27/08/2026
Silver Spring, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm [...]
Affordable ACA Alternatives: Common Healthcare Sharing Questions Answered for 2026
27/08/2026
Healthcare sharing organizations enroll year-round, with no ACA Open Enrollment window, making them accessible to people who need them at any time WeShare Health has shared more than $50 million in medical expenses for [...]
Stryker to participate in the 2026 Wells Fargo Healthcare Conference
27/08/2026
Portage, Michigan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026 , at the Encore Boston Harbor. Preston Wells, Vice [...]
JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering
27/08/2026
WESTFIELD, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- JATT III Acquisition Corp (the "Company") announced the closing of its initial public offering of 6,900,000 ordinary shares at an offering price of $10.00 per ordinary [...]
Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
27/08/2026
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune disease LISRAYA is a once-daily pill that directly targets key immune [...]
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
27/08/2026
LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune disease LISRAYA is a once-daily pill that directly targets key immune [...]
Music Beats Cancer Launches “Thumbs Up for a Cure” to Support the Next Generation of Childhood Cancer Treatments
27/08/2026
East Hampton gathering brings together families, biotech innovators, philanthropists, artists and the community to advance childhood cancer innovation EAST HAMPTON, N.Y., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Music Beats [...]
PRM Cosmetic Surgery Announces New Surgeon Training Initiative Led by Dr. Robert Rey
27/08/2026
Known as “Dr. 90210,” Dr. Rey returns to focus on surgeon education, Ayon technology and support for people living with lipedema Dr. Robert Rey, PRM Cosmetic Surgery. LOS ANGELES, Aug. 27, 2026 (GLOBE NEWSWIRE) -- PRM [...]
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
27/08/2026
HONG KONG, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced its interim results for the six months [...]
Recovery.com’s Tom Farley to Emcee National Recovery Month Kickoff
27/08/2026
MADISON, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Tom Farley, Community Outreach Director for Recovery.com, will emcee the 2026 Recovery Month Kickoff Luncheon on Thursday, September 3, at the Rayburn House Office [...]
Foundation for Sarcoidosis Research to Host Mid-Atlantic Regional Sarcoidosis Summit in Philadelphia
27/08/2026
Free educational summit brings together nationally recognized specialists, healthcare professionals, patients, and care partners to improve sarcoidosis care across the region PHILADELPHIA, Aug. 27, 2026 (GLOBE NEWSWIRE [...]
Benefits and Risks of Artificial Intelligence (AI) Scrutinized in the Journal of American Physicians and Surgeons
27/08/2026
TUCSON, Ariz., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) in medicine is portrayed as either a gateway to a golden era or a route to hell. In the fall issue of the Journal of American Physicians and [...]
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
27/08/2026
HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two [...]
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
27/08/2026
– Per-protocol interim statistical power analysis confirms no additional patients are recommended for full enrollment – – Second pivotal Phase 3 trial (COVE-3) has already exceeded 50% of current target enrollment, with [...]
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
27/08/2026
Research Shows that Patients with PSVT Experience a Substantial Burden Between Episodes, with Negative Impacts on Anxiety, Daily Activities, Sleep, and Work MONTREAL and CHARLOTTE, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE [...]
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
27/08/2026
Highlights of the second quarter include: Net income increased 10% to $65.6 million , and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million , and Adjusted EBITDA [...]
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
27/08/2026
Results from two Phase 2 clinical trials assessing tovinontrine in both major types of chronic heart failure will be presented at the Heart Failure Society of America annual scientific meeting BURLINGTON, Mass., Aug. 27 [...]
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
27/08/2026
Compatibility between the Galaxy™ System and premium GE HealthCare OEC C-arms reflects collaboration to expand access to advanced lung diagnostics SAN JOSE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Noah Medical today [...]
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
27/08/2026
Pivotal Phase 3 oPTimize trial design builds on positive Phase 2 Avail™ results and durable one-year clinical benefit Global registrational trial to enroll approximately 160 adults with HP to support once-weekly [...]

Pages